*the consideration payable is an aggregate of 42,777,000 fully paid ordinary shares at a deemed issue price of $0.30 and no cash;
*Completion is subject to a number of conditions precedent including shareholder approvals, third party change of control consents and entry into executive employment agreement with each of Garry Crole and Brent Jones to act as joint managing directors of InterPrac on and from Completion for 3 years;
*a total of 32,082,751 consideration shares to be subject to a voluntary escrow period of 12 months from Completion; and
*the vendors provide warranties and indemnities, including a warranty from management vendors that the InterPrac group has at least $2.2 million in net cash at Completion.
75% in escrow. The balance should create quite a bit of additional liquidity in December.
Previous experience is that markets are thin and irrational in the silly season. Anyone else see mid 20s for Christmas?
- Forums
- ASX - By Stock
- Ann: SEQ signs binding share sale agreement to acquire Interprac
SEQ
sequoia financial group ltd
Add to My Watchlist
1.43%
!
35.5¢

*the consideration payable is an aggregate of 42,777,000 fully...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $43.87M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $37.20K | 105.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 19052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50325 | 0.350 |
1 | 2944 | 0.340 |
1 | 2982 | 0.335 |
1 | 3000 | 0.330 |
2 | 69535 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 19052 | 2 |
0.360 | 134902 | 2 |
0.365 | 72540 | 3 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online